Search
Search Results
##search.searchResults.foundPlural##
-
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1353PDF: 886HTML: 1073Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 196 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2457PDF: 1057HTML: 5103Cover Letter: 179Figure 2: 179Figure 1: 186Figure 3: 212Figure 4: 182Figure Legend: 196Table 1: 204Table 2: 196Table 3: 193 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2251PDF: 1225HTML: 3891 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2675PDF: 1654HTML: 2440Table1: 206 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1170PDF: 524HTML: 380 -
-
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1314PDF: 1095HTML: 240 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3806PDF: 1512HTML: 319 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2043PDF: 751HTML: 716Table1: patient's characteristics: 167Table 2: profile of each patient: 191 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2876PDF: 1856HTML: 3756Pellagatti Fig 1: 233Pellagatti Fig. 2: 230 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2607PDF: 1196HTML: 151 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2308PDF: 1075HTML: 2023Characteristic of study group: 214 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1897PDF: 866HTML: 1615 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
754PDF: 477HTML: 6276 -
Osteolytic bone lesions – A rare presentation of AML M6.
2036PDF: 1137HTML: 7977Untitled: 214 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7754PDF: 2462HTML: 2102Table 1.: 234Table 2.: 242Table 3.: 226Table 4.: 219 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3205PDF: 1161HTML: 1678Untitled: 189Untitled: 184Untitled: 183 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1419PDF: 948HTML: 1674Figure 1: 189 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1602PDF: 790HTML: 2182Untitled: 235Untitled: 208Untitled: 206Untitled: 217Untitled: 210 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1948PDF: 803HTML: 554 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277744PDF: 1835HTML: 3889 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1845PDF: 733HTML: 419 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9248PDF: 6156HTML: 88023Fig.1b: 202Fig.1c: 210Fig.2a: 198Fig.2b: 194Fig.4: 216Fig.2c: 197Fig.3: 200Tab.1: 250Tab.2: 227Tab.3: 210Tab.4: 244Fig1a: 206 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
1991PDF: 1242HTML: 314 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1770PDF: 1132HTML: 10746Untitled: 201 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
5038PDF: 1340HTML: 1927Untitled: 194Untitled: 190 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2239PDF: 1644HTML: 386 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2418PDF: 1691HTML: 435







